Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 5 November 2026.

Announcements

6,266

Total raised

£165B

disclosed amounts

This month

£202M

raised so far

Seed
€7.5M

The seed round was led by Norrsken VC to help expand the company software for tracking renewable energy sources.

"One of the most effective things anyone can do to reduce their carbon footprint is to purchase energy from carbon-free sources. We’re helping energy companies create more transparent offers for their customers to make switching to clean energy more accessible and more impactful. Consumers deserve to know whether their electricity comes a source that is either destroying our planet or is part of our future."
— Toby Ferenczi, Co-Founder
Growth
£1.5M

The investment was backed by Mercia and Greater Manchester Combined Authority to help the firm scale its enterprise client base.

"Around 40 per cent of brands with a B2B-focus have still not adopted ecommerce, largely because of the challenge of transferring their business model online. Many companies who come to us do so on the back of a two-year failed attempt to launch a store fit for their business. Shopblocks offers a solution. The funding will help us attract more ‘enterprise’ clients and support our goal to become a £50m turnover business."
— Stewart Reynolds, Chief Commercial Officer

The funding round was led by 24Haymarket with participation from Foresight Group.

"Previsico’s flood forecasting technology provides users with early warnings to take preventative action to reduce damage and losses from flood water. The value proposition to its customers stretches beyond loss mitigation and importantly reduces the negative social impact of flooding. We are thrilled to support Previsico’s CEO Jonathan Jackson and his wider team on this exciting journey."
— Paul Hewitt, Investor Director
Series A
£8.3M

The financing will support the advancement of proprietary in vivo reprogramming therapies through pre-clinical translation.

"We are delighted to receive the continued support of Astellas Venture Management, Parkwalk Advisors and other existing investors as we relentlessly focus on progressing our novel pipeline of in vivo reprogramming therapies through pre-clinical translation. Aligned to a consolidated corporate structure and vision, this latest funding will provide sufficient cash runway to enable the achievement of key development milestones in both our internal programs as well as those being developed in collaboration with strategic partners. Existing investor commitment is a testament to our delivery of world-class science, expertise in cellular reprogramming and the unique potential of the MOGRIFY platform to deliver novel regenerative medicines to improve the lives of a broad spectrum of patients."
— Darrin Disley, CEO